Cessation of spread as a treatment objective in vitiligo: perception from the patients' point of view.

Vitiligo is an acquired condition resulting from the progressive loss of melanocytes.(1) It is known that the unpredictable nature of vitiligo and its tendency to progress can be psychologically overwhelming. In our previous clinical observational trials and during clinical practice we noticed frequently that disease stability is relevant for many patients.(2-4) Therefore, we wanted to evaluate the perception of disease impact, the general treatment motivation and the treatment motivation if disease stabilization would be the outcome. The second aim was to evaluate whether clinical variables may influence the impact of the disease and motivation for treatment. This article is protected by copyright. All rights reserved.